Heliyon (Jan 2024)
Corrigendum to “Cilengitide inhibits osteoclast adhesion through blocking the αvβ3-mediated FAK/Src signaling pathway” [Heliyon 9(7) (July 2023) e17841]
- Dan-yang Guo,
- Zhong-hua Chen,
- Yi-fei Fu,
- Yue-yue Li,
- Meng-nan Chen,
- Jun-jie Wu,
- Zheng-dong Yuan,
- Jun-Xing Ye,
- Xia Li,
- Feng-lai Yuan
Affiliations
- Dan-yang Guo
- Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China
- Zhong-hua Chen
- Fuyang Hospital of Anhui Medical University, Fuyang, Anhui, 236, China
- Yi-fei Fu
- Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China
- Yue-yue Li
- Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China
- Meng-nan Chen
- Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China
- Jun-jie Wu
- Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China
- Zheng-dong Yuan
- Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China
- Jun-Xing Ye
- Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China
- Xia Li
- Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China
- Feng-lai Yuan
- Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China; Corresponding author.
- Journal volume & issue
-
Vol. 10,
no. 1
p. e22629